Company ProfilePremium

Ryder Capital Limited

Company Profile Analysis

Ticker: RYD.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ryder Capital Limited - Company showcase

Year Founded & Workforce

2015

Ryder Capital Limited logo

Ryder Capital Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ryder Capital Limited Overview

Ryder Capital Limited is a small but distinctive Australian listed investment company. Through a closed-end vehicle, it gives retail and wholesale investors access to a concentrated, high-conviction, value-driven portfolio of ASX small- and micro-cap equities. Ryder Investment Management, a Sydney boutique founded in 2008 by Peter Constable, manages the portfolio. The strategy targets absolute returns above the RBA cash rate plus 4.25% rather than tracking an index. It typically holds about 25–35 positions, and the top ten holdings often exceed 60% of capital.

FY26 was the third consecutive year of net returns above 25%:

  • Pre-tax NTA return of 33.53%

  • Gross portfolio return of 37.59%, against 8.11% for the Small Ordinaries Accumulation Index

  • Record total comprehensive income of A$31.80m

The manager owns about 22.7% of the shares through director-related interests, which creates strong alignment. The trade-offs are key-person concentration, limited board independence, and a high-fee structure (1.25% management fee plus a 20% performance fee).


What the company does

Ryder Capital is a pure investment holding company. Its sole activity is investing a concentrated portfolio of ASX-listed small- to mid-capitalisation securities, plus bonds and cash. It may also hold unlisted securities and derivatives (options and warrants) incidental to its equity positions.

In its FY26 Directors' Report, the Company describes its principal activity as investing in such a portfolio in line with its permitted investments. Its objective is long-term capital growth above its benchmark (RBA cash rate plus 4.25% p.a.), under the 12 August 2015 Prospectus. Day-to-day investment decisions sit with the external Investment Manager.

Business model and "revenue" model

Economic leverDescriptionFY26 figure (AUD)FY25 figure (AUD)Source
Dividend income (net of franking)Dividends from investee companies2,444,3502,681,391FY26 P&L
Interest incomeInterest on cash (weighted average rate 3.68% at June 2026)770,127598,883FY26 P&L, Note 2
Net gain on FVTPL instrumentsMark-to-market on options and warrants1,360,159668,315FY26 P&L
Other incomeSundry5264,287FY26 P&L
Total investment income ("revenue from ordinary activities")—4,575,1623,952,876FY26 Appendix 4E
Movement in fair value of long-term equity investments (OCI, net of tax)Realised and unrealised gains on the core portfolio, taken through OCI under the AASB 9 FVOCI election31,368,84119,594,671FY26 P&L/OCI
Total comprehensive incomeHeadline economic measure31,800,23721,813,017FY26 P&L/OCI

An LIC has no products or customers in the conventional sense. Its economics work as follows:

Accounting mechanics. The Company has irrevocably elected to measure its long-term equity investments at fair value through other comprehensive income (FVOCI). As a result, realised and unrealised capital gains on the portfolio bypass statutory profit. Statutory net profit (A$0.43m in FY26) therefore captures only income less expenses and tax. It is a poor guide to economic performance, and management itself directs investors to total comprehensive income.

Realised gains after tax are transferred within equity, from the asset revaluation reserve to a capital profits reserve. That reserve then funds dividends. In FY26, A$25.19m of realised after-tax gains moved into the capital profits reserve, which closed at A$47.61m.

Cost structure. Costs comprise:

  • A management fee of 1.25% p.a. plus GST on portfolio net asset value

  • A performance fee of 20% plus GST of outperformance over the benchmark. It accrues monthly, is paid annually, and carries forward any deficit (a high-water-mark style mechanism)

  • Directors' fees (A$80,000 in FY26)

  • Portfolio management expense recoveries (A$254,555)

  • Other operating costs (A$395,828)

Total FY26 expenses were A$5.06m, of which the performance fee accounted for A$2.18m.

Value-chain position, customers and end-markets

DimensionCharacterisation
Value-chain positionA permanent-capital provider to the ASX small/micro-cap market. It provides IPO and placement capital (for example the FDC Consolidated IPO in June 2026 and the Tetratherix IPO in July 2025) and acts as a significant, sometimes engaged, shareholder in investee companies
"Customers" (capital providers)Australian retail investors, self-managed super funds (SMSFs), high-net-worth individuals, and the manager and directors themselves (about 22.7% of shares)
End-markets of exposure (30 June 2026 sector mix)Materials 20.8%, Financial Services 20.1%, Technology 18.9%, Industrials 13.0%, Healthcare 12.3%, Consumer Discretionary 3.8%, Media & Entertainment 2.9%, Energy 1.2%, Cash 6.9% (FY26 Annual Report)
Value proposition to shareholdersFully franked dividend income (12 cps p.a.), capital growth, and access to concentrated small-cap expertise. The closed-end structure suits illiquid micro-caps because it avoids redemption pressure

Independent characterisation

Ryder is a high-conviction, benchmark-agnostic, value-biased small-cap fund wrapped in an LIC. Its return profile is lumpy. Annual pre-tax undiluted NTA returns ranged from −21.47% (FY22) to +33.72% (FY21), per the September 2026 Shareholder Letter heatmap.

Its outcomes are driven by a few large positions:

FY26: Macmahon contributed about A$13.5m and BCI Minerals was 14.7% of the portfolio at June 2026.

September 2026: BCI had grown to 20.14% of the portfolio.

The manager is willing to hold unlisted and venture-like assets (Updater Technologies, and previously Vitrafy convertible notes). It participates in IPOs, uses options where they arise, and will exit on governance grounds (Humm Group in FY26).

Because the board is dominated by the manager's principals, governance looks more like a family-office vehicle than a widely held institutional LIC.

Strategy

Stated strategy (themes from the FY26 Annual Report and NTA reports)

Ryder's stated investment pillars, from its monthly NTA reports, are:

  • An absolute-return, value-driven, fundamental approach

  • Outperforming the RBA cash rate plus 4.25% over the medium to longer term

  • A concentrated, high-conviction portfolio of ASX small and micro-caps

  • Medium- to long-term capital growth

The manager describes its differentiation as a long holding horizon, meaningful co-investment in the Company, and putting absolute returns first. It attributes its success to avoiding mistakes, ignoring consensus, and backing its own judgement.

Initiatives in the last 24 months

DateInitiativeDetail / targetStatus
19 Feb 2024DRP launchAllow reinvestment of dividendsSuspended 8 Jul 2025 (while shares traded at a wide discount, issuing scrip would have been dilutive)
FY25 to FY26On-market buy-back1,641,386 shares (FY25) and 450,000 (FY26)Inactive since about January 2026 as the discount narrowed; to resume when meaningfully NTA-accretive
15 Oct 2025Enhanced dividend policyQuarterly 3.0 cps fully franked; 12 cps annualised (+20% on FY25); imputation rate raised to 30%Implemented; four quarterly dividends declared so far (Dec-25, Mar-26, Jun-26, Sep-26)
FY26Portfolio rotation into "SaaSpocalypse" softwareNew positions in SiteMinder, Vista, Gentrack and FineosMixed: Gentrack −73% in FY26; SiteMinder a detractor in Aug/Sep 2026
FY26Profit realisationNet A$35.98m realised gains, including the full Macmahon exitCompleted
FY26 to FY27Cash rebuildCash 6.89% at June 2026 seen as a low point; 8.85% at September 2026, still below targetOngoing
FY26Governance refreshNew Company Secretary; auditor change to Pitcher PartnersCompleted
OngoingESG / sustainability programmeNone disclosed—
OngoingCost programmeNone disclosed; fees are contractual—

Medium-term targets and guidance

ItemTarget / guidanceSource
Return objectiveExceed RBA Cash Rate + 4.25% p.a. over the medium to long termProspectus
FY27 dividendMinimum 3.0 cps per quarter fully franked (12.0 cps); "steady to increasing" over timeFY26 Annual Report
Dividend coverageMore than five years of fully franked dividend coverage from reserves and portfolio income. About A$0.73 per share profits reserve at 30 Sep 2026, of which about A$0.57 per share is distributable fully frankedFY26 Chairman's Letter; Sep-26 Letter
Return expectationManagement anticipates another strong year in FY27, describing the portfolio as cheap relative to intrinsic valueFY26 Investment Manager's Report
Earnings guidanceNone (not applicable for an LIC)—

Products & Services

For an LIC, the "product" is the listed share (RYD) and the underlying investment strategy. The "catalog" is the investment portfolio. Both are set out below.

Listed product

ProductDescriptionTarget investorLaunchPricing / cost
RYD ordinary shares (ASX)Closed-end exposure to the Ryder small-cap strategy with quarterly fully franked dividendsRetail, SMSF, HNW22 Sep 2015Market price (A$2.14 at 30 Sep 2026); 1.25% p.a. management fee plus 20% performance fee over RBA + 4.25%
RYDO / RYDOA options (historic)Listed options issued around listing / follow-on; 26.7m and 26.5m exercisedExisting shareholdersc.2015 to 2016 (exact dates n/d)Exercised; none outstanding (FY26 Note 10)
Dividend Reinvestment PlanDRP commenced 19 Feb 2024Existing shareholdersFeb 2024Suspended since 8 Jul 2025
On-market share buy-backAccretive capital managementAll holders (indirect)Ongoing; 450,000 shares bought in FY26 at A$1.65 averageInactive in 2H FY26 and the Sep-26 quarter as the discount narrowed

Related manager product (not a Company product): the Ryder Innovation Fund, referenced in the FY26 report as the vehicle through which the manager first knew Tetratherix. Its details are not publicly disclosed in the sources reviewed.

Investment strategy specifications

AttributeSpecificationSource
StyleAbsolute-return, value-driven, fundamental, bottom-upNTA reports
UniverseASX-listed small and micro-caps; selective unlisted and pre-IPONTA reports; FY26 portfolio
ConcentrationHigh conviction; 34 line items (about 30 issuers) at June 2026; top 10 equal to 62.6% of assetsFY26 portfolio table
HurdleRBA Cash Rate + 4.25% p.a. (about 8.85% at a 4.60% cash rate after the RBA's 29 Sep 2026 hike)Sep-26 Shareholder Letter
Risk controlsMinimum "margin of safety" parameters; maximum single-stock and sector limits per ProspectusFY26 Note 2(d)
DerivativesPermitted for hedging, substitution and exposure management; in practice limited to options and warrants receivedFY26 Note 8
FXMay hedge; Updater US-dollar exposure unhedgedFY26 Note 3(d)
GearingNone usedFY26 Balance Sheet

Full portfolio catalog at 30 June 2026 (FY26 Annual Report)

#HoldingTickerValue (AUD)Weight (%)Business description (analyst summary)
1BCI MineralsBCI23,828,95014.72Developer of the Mardie Salt & Sulphate of Potash Project, Western Australia
2CountCUP13,354,6508.25Vertically integrated financial advice, wealth and accounting network
3Vitrafy Life SciencesVFY10,126,3476.26Cryopreservation technology (Guardion units) for blood, cell & gene therapy and animal reproduction
4CuscalCCL9,821,7396.07Payments and banking infrastructure provider; acquired Indue and Paymark (NZ)
5OFX GroupOFX9,410,0395.81Cross-border payments; subject to a A$1.00 cash proposal from Equals
6Chrysos CorporationC799,382,0405.80PhotonAssay technology replacing fire assay in mineral testing
7Lumos DiagnosticsLDX8,324,7885.14Point-of-care diagnostics; FebriDX received CLIA Waiver in March 2026
8SiteMinderSDR7,334,9344.53Hotel distribution and channel-management software
9Fineos CorporationFCL5,185,9503.20Core systems software for life, accident and health insurers
10Updater Technologies (Series A Pref)Unlisted4,945,9803.06US relocation/HOME platform (Delaware)
11Polymetals ResourcesPOL4,752,4722.94Base/precious metals producer (exited Sep-26 qtr)
12GentrackGTK4,474,7022.76Utility billing and airport software
13Symal GroupSYL4,133,3772.55Civil infrastructure contractor
14SRG GlobalSRG3,984,6652.46Engineering and maintenance services
15Coast EntertainmentCEH3,892,6842.40Theme parks, Gold Coast (exited Sep-26 qtr)
16AirtaskerART3,888,5852.40Services marketplace (Australia, UK, US)
17FDC ConsolidatedFDC3,562,5002.20IPO June 2026, listed 9 July 2026 (exited Aug-26)
18Hillgrove Resources (now Kantra Copper)HGO2,635,5901.63South Australian copper producer
19Vista GroupVGL2,515,1881.55Cinema-industry software (NZ/ASX)
20NufarmNUF2,287,4701.41Crop protection and seed technologies (exited Sep-26 qtr)
21Adore Beauty GroupABY2,285,8961.41Online and physical beauty retail
22Janison Education GroupJAN2,229,3061.38Digital assessment platform
23Urbanise.comURB1,552,8780.96Strata/facilities management SaaS
24Amplitude EnergyAEL1,546,4930.96East-coast gas producer
25TetratherixTTX961,6800.59Biomaterials / medtech (IPO July 2025)
26Updater Technologies (Common)Unlisted926,7650.57As above
27Updater Technologies (Warrants)Unlisted884,7100.55As above; strike US$0.75, expiring June 2029
28Commschoice GroupCCG807,5000.50Telecommunications / cloud communications
293P Learning3PL607,6970.38Online education (Mathletics)
30Lumos Diagnostics (Options)Unlisted546,3520.34Exercised September 2026 at 7 cents
31Omega Oil & GasOMA373,2150.23Queensland gas exploration
32Valiant GoldVAL133,3330.08Gold exploration
33TubiUnlisted37,4740.02In members' voluntary liquidation (about 1.6 cents expected return)
34DuratecDUR1,0120.01Asset remediation contractor (residual)
—Total equities—150,736,96193.11—
—Cash (incl. settlements/receivables)—11,147,0816.89—

Key position weights at 30 September 2026 (Sep-26 Shareholder Letter)

HoldingWeight (%)Quarterly move (as reported)
BCI Minerals20.14+57.0%
Count8.80+42.2% (incl. dividends)
Vitrafy Life Sciences7.25+32.9%
Cuscal6.47+23.7% (incl. dividends)
Chrysos5.78+14.5%
OFX Group5.68+10.8%
Lumos Diagnostics5.00−4.8%
Cash8.85—

New small positions in the September 2026 quarter: Objective Corporation, SCX.AI, Mitchell Services and Generation Development Group, together about 1.8% of the portfolio.

Exits in July to September 2026: FDC Consolidated, Nufarm, Coast Entertainment and Polymetals Resources.

Financial Narrative

Data conventions:

  • "n/d" means not publicly disclosed in the sources reviewed.

  • FY2025 and FY2026 are audited (FY26 Annual Report).

  • FY2022 to FY2024 come from the FY26 Remuneration Report five-year table, prior releases, or InvestSMART (flagged in the notes).

  • An LIC has no gross profit, EBITDA, capex or goodwill in the conventional sense. Those lines are shown as 0 or n/a with explanation.

Income statement

Notes to 6.1:

  • Statutory net profit and dividends declared per share are from the FY26 Remuneration Report five-year table.

  • FY23 and FY24 investment income and EPS are InvestSMART aggregates, not reconciled to audited statements.

  • FY24 total comprehensive income (≈18.2) is derived from the FY25 release's "+20% to A$21.8m". A Quartr summary describes FY24 income as up 363%. Because the FY23 NTA return was negative (−8.85%), that growth rate cannot be reconciled reliably, so FY23 total comprehensive income is left as n/d.

Dividend timing: "Dividends declared" in FY26 (9.0 cps) reflects the switch to quarterly declarations: three 3.0 cps dividends were declared within FY26, and the June-quarter dividend was declared on 1 July 2026. Dividends paid in FY26 were 11.5 cps (the 5.5 cps FY25 final plus two quarterlies), per the FY26 Directors' Report.

Margins and growth (analyst-computed from audited data)

Average net assets: FY25 = (114.29 + 126.69)/2 = A$120.49m; FY26 = (126.69 + 148.46)/2 = A$137.57m.

Commentary. The headline driver in FY26 was the A$31.37m fair-value uplift through OCI. Within it, the portfolio realised A$35.98m of net gains (A$38.79m gross gains, A$2.81m gross losses). Statutory profit fell 80.6% to A$0.43m. The reason was the A$2.18m performance fee, which crystallised after the carried-forward deficit of A$4.61m at June 2025 was fully recovered. Statutory profit does not reflect weaker operations.

The effective tax rate of −189% reflects franking-credit offsets against a small pre-tax loss. Gross margin, operating margin and EBITDA margin are not meaningful for an LIC. Investment income growth of 15.7% came mainly from higher interest income on larger cash balances and higher FVTPL option gains; dividend income was lower.

Balance sheet

Notes to 6.3:

  • FY23 equity is from InvestSMART.

  • FY24 equity, cash and current tax are from the FY26 Statement of Changes in Equity, Cash Flow Statement and Note 4 opening balances.

  • FY22/FY23 NTA figures are from the FY26 Remuneration Report and the FY23 Appendix 4E comparatives.

  • The FY25 net deferred tax figure is a net deferred tax asset of A$0.28m.

  • Distributable profit reserves per share are read from the FY26 Directors' Report chart.

Equity composition at 30 June 2026 (A$):

The swing from a A$1.10m deficit to a A$5.08m surplus in the revaluation reserve shows that unrealised gains are now embedded in the book.

Fair value hierarchy at 30 June 2026 (A$):

Level 3 assets more than doubled from A$2.68m, after an independent limited-scope valuation of Updater at a 17.5% discount rate and 2.5% terminal growth.

Cash flow

FY23/FY24 operating, investing and financing flows are InvestSMART rounded aggregates. Dividends paid FY22 to FY24 are from the FY26 Remuneration Report. For an LIC, "free cash flow" is defined here as operating plus net investing flows, since portfolio turnover is the business. This is an analyst definition.

Commentary. Operating cash flow turned negative mainly because tax paid on realised gains rose: tax paid of A$6.58m in FY26 versus A$2.62m in FY25. Realised gains are taxed but sit in investing flows, while the tax on them sits in operating flows. Net portfolio realisations (A$21.6m) comfortably funded A$9.29m of dividends and A$0.87m of buy-backs, and still lifted cash by A$4.98m.

Tax paid feeds the franking account. The account closed FY26 at A$10.95m, rising to A$19.28m adjusted for current tax payable. This is the engine behind the 12 cps fully franked dividend commitment.

Performance history (economic "top line")

Sources: the Sep-26 Shareholder Letter heatmap (undiluted, FY22 to FY26), the FY25 Appendix 4E and the FY26 Annual Report.

Pre-tax NTA per share CAGR, FY22 to FY26: about 9.9% a year, before adding back dividends paid (computed: (1.9805/1.36)^(1/4) − 1). Including dividends, the reported 5-year pre-tax undiluted NTA return to June 2026 was 8.69% p.a. The difference reflects the FY22/FY23 drawdowns falling at the start of the window.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleOwnership / control

Ryder Capital Limited

ASX-listed LIC; holds all investments

Public shareholders; directors and related parties hold about 22.7%

Ryder Investment Management Pty Ltd

External Investment Manager (AFSL 328 971); earns management and performance fees; holds 4,194,000 RYD shares

Privately owned; controlled by Peter Constable

Apex (administrator, as referenced in NTA source notes)

Fund administration / NTA calculation (inferred from "Source: Bloomberg + Apex")

Third party

Share registry

External provider (identity not captured in sources reviewed)

Third party

Results by Segment and Revenue by Segment (%)

MetricFY2024FY2025FY2026

Total investment income (AUD Mn)

3.73.954.58

Profit before tax (AUD Mn)

—1.85-0.49

Total comprehensive income (AUD Mn)

18.221.8131.80

Share of total revenue (%)

100100100

Sector Details

SectorWeight at 30 Jun 2026 (%)Anchor holdings

Materials

20.8

BCI Minerals, Polymetals, Hillgrove (Kantra Copper), Valiant Gold

Financial Services

20.1

Count, Cuscal, OFX Group

Technology

18.9

SiteMinder, Fineos, Gentrack, Vista, Airtasker, Janison, Urbanise, Updater

Industrials

13.0

Chrysos, Symal, SRG Global, Duratec

Healthcare

12.3

Vitrafy, Lumos Diagnostics, Tetratherix

Cash

6.9

Includes settlements and receivables

Consumer Discretionary

3.8

Adore Beauty, Coast Entertainment

Media & Entertainment

2.9

Vista Group (cinema software, classification per manager)

Energy

1.2

Amplitude Energy, Omega Oil & Gas

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total investment income (AUD Mn)

—3.23.73.954.58

Dividend income net of franking (AUD Mn)

———2.682.44

Interest income (AUD Mn)

———0.600.77

Management fees (AUD Mn)

———1.612.15

Performance fees (AUD Mn)

———02.18

Total expenses (AUD Mn)

———2.115.06

Profit before tax (AUD Mn)

———1.85-0.49

Income tax benefit (AUD Mn)

———0.370.92

Statutory net profit after tax (AUD Mn)

3.481.512.032.220.43

OCI: fair value movement net of tax (AUD Mn)

———19.5931.37

Total comprehensive income (AUD Mn)

——18.221.8131.80

Basic and diluted EPS (AUD cents)

—1.82.42.720.53

Dividends declared per share (AUD cents)

7.007.259.0010.009.00

Dividends paid per share (AUD cents)

———9.511.5

Margin Analysis (%)

MetricFY2025FY2026

Expense ratio excl. performance fee (% of average net assets)

1.752.09

Expense ratio incl. performance fee (% of average net assets)

1.753.68

Total comprehensive income / average net assets (%)

18.123.1

Statutory net profit / total investment income (%)

56.19.4

Investment income growth YoY (%)

—15.7

Total comprehensive income growth YoY (%)

20.045.8

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

———132.48165.82

Cash and equivalents (AUD Mn)

——1.8210.0415.02

Investments at fair value (AUD Mn)

———121.88150.74

Total debt / borrowings (AUD Mn)

———00

Net debt (AUD Mn; negative = net cash)

———-10.04-15.02

Total liabilities (AUD Mn)

———5.7917.36

Current tax liability (AUD Mn)

——0.555.408.33

Deferred tax liability, net (AUD Mn)

———-0.282.74

Net assets / equity (AUD Mn)

—104.6114.29126.69148.46

Goodwill and intangibles (AUD Mn)

00000

Working capital: current assets less current liabilities (AUD Mn)

———4.601.89

Pre-tax NTA per share (AUD)

1.361.191.38751.62721.9805

Post-tax NTA per share (AUD)

1.401.25—1.56401.8430

Shares on issue (M)

——82.3081.0080.55

Distributable profit reserves per share (AUD)

———0.640.72

Components

ComponentAmount (AUD)

Issued capital

98,307,847

Accumulated losses

(12,720,390)

Profits reserve

10,180,019

Capital profits reserve

47,612,271

Asset revaluation reserve

5,077,508

Group Structure

LevelHoldingsAmount (AUD)Share of investments

Level 1

Listed equities

139.83m

92.8%

Level 2

FDC IPO shares and options

4.99m

3.3%

Level 3

Updater and Tubi

5.91m

3.9%

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Net operating cash flow (AUD Mn)

—1.561.24-1.37-6.49

Income tax paid (AUD Mn)

———2.626.58

Proceeds from sale of investments (AUD Mn)

———81.1790.62

Purchases of investments (AUD Mn)

———62.2968.99

Net investing cash flow (AUD Mn)

—1-118.8821.62

Capex (AUD Mn)

00000

Free cash flow: operating + net investing (AUD Mn)

—2.60.217.5115.14

Dividends paid, cash net of DRP (AUD Mn)

5.615.916.577.389.29

Share buy-backs, cash (AUD Mn)

———1.910.87

Net financing cash flow (AUD Mn)

—-7-8-9.29-10.16

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2025FY2026Comment

ROE on total comprehensive income (%)

18.123.1

Economic return on average equity

ROE on statutory profit (%)

1.80.3

Distorted by FVOCI accounting

ROA on total comprehensive income (%)

—21.3

Average total assets FY26 = A$149.15m

Current ratio (x)

1.791.13

FY26 inflated liabilities: A$3.92m broker settlements, A$2.18m performance fee, A$8.33m tax

Debt / equity (x)

0.000.00

Ungeared

Asset turnover: sales proceeds / average assets (x)

—0.61

Portfolio turnover proxy

Payout ratio: dividends paid / total comprehensive income (%)

33.829.2

Sustainable on an economic basis

Margin Analysis (%) (FY2022–FY2026)

MetricFY2022FY2023FY2024FY2025FY2026

Pre-tax undiluted NTA return (%)

-21.47-8.8524.9627.1633.40

Pre-tax diluted NTA return (%)

———27.5033.53

Gross portfolio return (%)

———29.4537.59

Hurdle: RBA cash + 4.25% (%)

———8.488.09

S&P/ASX Small Ords Accumulation (%)

————8.11

S&P/ASX All Ords Accumulation (%)

————5.70

Region Assets & Liabilities and Region Assets & Liabilities (%)

MetricFY2025FY2026

USD-denominated financial assets (AUD Mn)

2.656.76

AUD-denominated financial assets (AUD Mn)

129.56159.06

USD assets share of total financial assets (%)

2.04.1

Share Price and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Share price (AUD)

1.300.971.131.301.73

Pre-tax NTA per share (AUD)

1.361.191.38751.62721.9805

Premium / (discount) to pre-tax NTA (%)

-4.4-18.5-18.6-20.1-12.6

Market capitalisation (AUD Mn)

—80.892.6105.3139.4

Total shareholder return (%)

—-21.326.124.841.92

Valuation Snapshot

MetricValue

Share price

A$2.14

Pre-tax / post-tax NTA

A$2.2395 / A$2.0175

Discount to pre-tax NTA

−4.4%

Premium to post-tax NTA

+6.1%

Market capitalisation

A$172.38m

Cash

A$16.44m

Enterprise value (market cap less cash)

About A$155.9m (analyst)

Change by Period

PeriodChangeBasis

~1 year

About +33%

A$1.61 at the 15 Oct 2025 release to A$2.14 at 30 Sep 2026

3 years

+78%

30 Jun 2023 to 30 Jun 2026

5 years

Not available; 4-year +33% instead

—

Valuation Multiples

MultipleRYDComment

P/E (statutory)

About 400x

Not meaningful (FVOCI accounting)

Price / total comprehensive income per share

About 5.4x

FY26 total comprehensive income of about 39.4 cps

EV/Sales (investment income)

About 34x

Not meaningful

P/B (price / pre-tax NTA)

0.96x

Key LIC metric

P/B (price / post-tax NTA)

1.06x—

Cash dividend yield

5.61%—

Grossed-up yield

About 8.0%

Analyst; 30% franking

Per-Share Data and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Dividends declared (AUD cents per share)

7.007.259.0010.009.00

Franking (%)

100100100100100

Capital Markets

ItemDetail

Buy-backs

On-market buy-back active. FY25: 1,641,386 shares for A$2.04m. FY26: 450,000 shares at an average A$1.65 (A$0.74m). None since about January 2026 and none in the Sep-26 quarter. The Board intends to buy back when it is meaningfully NTA-accretive. Authorisation limits n/d

Credit ratings

None (Moody's, S&P and Fitch: not rated). No debt

Debt maturity profile

Not applicable. All liabilities (A$17.36m at June 2026: trade payables, tax, deferred tax) are non-interest-bearing; financial liabilities are due within one month

Analyst Conclusions

Management guidance

FY27 dividend: a minimum of 12.0 cps fully franked, paid quarterly.

Return outlook: the manager expects another strong year, citing several core holdings trading well below intrinsic value. It also warns that equities may underperform or be hard to navigate given:

  • Re-accelerating inflation

  • Central-bank tightening

  • The Middle East conflict

  • AI-driven disruption

Cash: to be rebuilt above the 8.85% September level by trimming overweight winners.

Buy-back: to resume only when accretive.

FY27 started at +14.88% for the September quarter.

Consensus

Not available (no broker coverage identified).

Bull case

  1. Embedded catalysts. BCI (20% weight) moves from construction to cash flow, with first salt on ship in the March quarter of 2027 and the sulphate of potash pilot advancing. OFX completion at A$1.00 would add roughly A$4m (about 5 cps of NTA) versus the September mark. Vitrafy's US blood-network roll-out (about 18% of the addressable market already partnered) could re-rate a 7% position.

  2. Proven process with a compounding track record. The since-inception profit-to-loss multiple of 4.80x, a 3-year return of 34.22% p.a. and a since-inception return of 12.98% p.a. (both diluted, to September 2026) suggest skill rather than luck. Rising cash gives optionality in a tightening market.

  3. Income and structural support. A 72 cps distributable reserve and a A$19.3m adjusted franking balance underwrite a fully franked yield of 5.6% (about 8% grossed up). The narrowed discount (−4.4%) could flip to a premium, enabling accretive capital raising.

Bear case

  1. Concentration and macro risk. With BCI at about 20% and the top seven positions at about 59%, a single project delay (cyclones already pushed out first salt) or a small-cap derating under a 4.60% cash rate could reverse gains quickly. 2H FY26 already delivered −8.88%.

  2. Fee drag and governance. FY26 costs equalled about 3.7% of average net assets. The performance hurdle (cash + 4.25%) is easier to beat than an equity index in strong markets. With one independent director and an executive chair who controls the manager, minority shareholders have limited checks.

  3. Valuation and deal fragility. OFX's financing uncertainty and FY27 downgrade (A$0.615 versus A$1.00 offer), Level 3 Updater marks (A$6.76m on a 17.5% discount-rate DCF), and recent software holdings that disappointed (Gentrack −73%; SiteMinder downgrade) show that mark-to-market gains are not locked in.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
21 Oct 2026AGM: FY27 year-to-date update; director re-elections; any capital-management signals
By 30 Oct 2026OFX/Equals: debt financing, SID execution, scheme timetable
Monthly (about the 7th–10th)NTA reports: discount/premium, cash level, BCI weight
Late Dec 2026 / early Jan 2027Q2 FY27 dividend (minimum 3.0 cps)
End of calendar 2026Vitrafy FDA registration/listing; Lumos US flu-season sales of FebriDX
Feb 20271H FY27 results (InvestSMART lists 18 Feb 2027)
Mar quarter 2027BCI first salt on ship at Mardie
OngoingRBA policy path; Updater revaluation; buy-back reactivation; any board-independence changes

Concluding analyst verdict

Ryder Capital has evolved from a niche boutique LIC that endured two difficult years (FY22 −21.5%, FY23 −8.9%) into one of the best-performing listed equity vehicles on the ASX. It delivered three consecutive years of net returns above 25%, record total comprehensive income of A$31.8m in FY26, and a further +14.9% in the September 2026 quarter.

The quality of these returns is notable. The gains are driven by identifiable business progress (Count, Cuscal and Chrysos all posted record results, and BCI produced its first salt). Realised profits are high: A$36m net in FY26 alone. Risk-adjusted metrics materially exceed those of the indices. The board has converted that performance into a credible income proposition: a 12 cps fully franked dividend backed by about 72 cps of distributable reserves.

Against this, investors must accept a deliberately concentrated, high-volatility portfolio. BCI alone is about 20% of assets, and both the OFX takeover and the Level 3 Updater valuation carry completion and valuation risk. Fees are expensive by LIC standards. Governance falls short of ASX best-practice recommendations: an executive chair who controls the manager, a single independent director, and a cross-directorship with a top holding. The macro backdrop of rising rates, re-accelerating inflation and US$100 oil is unfriendly to small caps. At 0.96x pre-tax NTA, the historic discount buffer has largely disappeared.

The next 6–9 months should be binary-skewed positive: OFX completion and BCI's first shipment are tangible NTA catalysts. However, the stock's re-rating means new money is no longer buying at a discount. On balance, the evidence supports a constructive but valuation-aware stance. The key monitorables are OFX completion, BCI execution, cash rebuilding and any improvement in board independence.


Data limitations: - The supplied ISIN (US7835491082) relates to Ryder System, Inc. and does not identify this company.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointed / tenureBackgroundEducationOther listed boards

Peter Constable

Executive Chairman; CIO of the Investment Manager; Audit & Risk Committee member

Director since 26 Jun 2015 (about 11 years); Executive Chairman since inception

30+ years in equity capital markets. Began career in 1993 at United Bank of Kuwait, London. Founded AM Constable (1999), which merged with MMC Asset Management in 2003; CIO/ED of MMC to June 2008. Co-founded Ryder Investment Management in July 2008

BEc (Macquarie University)

—

Lauren De Zilva CFA

Executive Director; Portfolio Manager; Audit & Risk Committee member

Appointed 4 March 2025 (about 1.6 years); joined Ryder in 2018

8+ years in equity markets; previously an intern at Commonwealth Bank of Australia

BActSt, BAppFin (Macquarie University); CFA charterholder; GAICD

—

David Bottomley

Non-Executive Director; Audit & Risk Committee member

Director since 26 Jun 2015. Executive Director to 4 Mar 2025, then NED. Retired as Company Secretary 4 Mar 2025

25+ years in corporate finance, M&A and ECM. Kleinwort Benson (UK), Merrill Lynch (London), MD Australia of GMCG LLC (2004–2008). Co-founder of the Investment Manager; ceased as its director 10 Mar 2025

BA (Economic History, University of Sydney), LLB (Hons, Bond University), F Fin

None current; Tetratherix Ltd director March 2020 to December 2025

Ray Kellerman

Independent Non-Executive Director; Chair of Audit & Risk Committee

Appointed June 2015 (about 11 years)

35+ years in funds management and structured finance. Ten years at Perpetual Trustees; own compliance consultancy since 2001. Former Independent Chair of ClearView Wealth and of Credit Suisse Asset Management Australia

BEc, LLB, MBA, F Fin

Chairman of Count Limited (ASX: CUP), director since January 2017

Executive Leadership Team

NameRole

Peter Constable

Chairman and Chief Investment Officer

Lauren De Zilva CFA

Portfolio Manager and Director

Alex Grosset

Assistant Portfolio Manager

Directors' Remuneration

DirectorFY26 feesFY26 superFY26 totalFY25 total

Peter Constable

0000

Lauren De Zilva

0000

David Bottomley

35,7144,28640,00010,000

Ray Kellerman

35,7144,28640,00040,000

Total

71,4288,57280,00050,000

Directors' Remuneration (FY25 (AUD)–FY26 (AUD))

FeeFY26 (AUD)FY25 (AUD)

Management fee

2,151,7561,608,380

Performance fee

2,179,125 (payable after the FY26 audit)

0

Directors' Remuneration (FY2022–FY2026)

MetricFY2022FY2023FY2024FY2025FY2026

Total directors' remuneration (AUD K)

4040405080

Governance Overview

AttributeAssessment

Board size

4

Independent directors

1 of 4 (Kellerman)

Chair / CEO separation

No. The Chairman is also CIO of the external manager, which does not meet ASX Corporate Governance Council Recommendations 2.4 and 2.5 (majority independent board; independent chair)

Committees

Audit & Risk Committee: all four directors, chaired by Kellerman. No separate nomination or remuneration committee disclosed

Meetings FY26

Board 3 of 3 attended by all directors; ARC 2 of 2 attended by all

Cross-directorship

Kellerman chairs Count Limited, Ryder's second-largest holding (8.25% at June 2026; 8.80% at September 2026). This is a potential conflict requiring careful information-barrier management

Related-party exposure

Bottomley was a Tetratherix director (to Dec 2025) while Ryder participated in the July 2025 Tetratherix IPO. The FY26 report notes that the manager knew Tetratherix through the Ryder Innovation Fund

Auditor rotation

Grant Thornton replaced by Pitcher Partners for FY26 (reason not disclosed)

Board & Management Changes

DateChange

4 Mar 2025

De Zilva appointed Executive Director; Bottomley moves to NED and retires as Company Secretary

10 Mar 2025

Bottomley ceases as director of the Investment Manager

May 2026

Jane Corish appointed Company Secretary. The interim secretary between March 2025 and May 2026 was not identified in the sources reviewed

Major Shareholders

HolderShares% of 80,549,795

Peter Constable (incl. 4,194,000 held by the Investment Manager)

13,495,83216.75

David Bottomley

2,950,0003.66

Ray Kellerman

1,800,0002.23

Lauren De Zilva

64,9970.08

Total directors and related

18,310,829

22.73

Competitive Landscape

Key Competitors

#Competitor (ASX code)ManagerStrategy overlapRelative positioning vs RYD
1

WAM Microcap (WMI)

Wilson Asset Management

ASX micro-caps

Larger, more diversified, highly liquid retail franchise

2

WAM Capital (WAM)

Wilson Asset Management

Small/mid-cap, market-driven plus research

Much larger; flagship retail LIC

3

WAM Research (WAX)

Wilson Asset Management

Small/mid-cap research-driven

Larger; dividend-focused

4

NAOS Small Cap Opportunities (NSC)

NAOS Asset Management

Concentrated, engaged small-cap

Most similar concentrated style; has faced discount and performance pressure

5

NAOS Emerging Opportunities (NCC)

NAOS

Concentrated micro-cap

Similar style

6

Thorney Opportunities (TOP)

Thorney Investment Group

Concentrated, activist small-cap

Similar high-conviction, manager-aligned model

7

Spheria Emerging Companies (SEC)

Spheria Asset Management

Small/micro-cap value

Value-style peer

8

Sandon Capital Investments (SNC)

Sandon Capital

Activist small-cap

Engagement-driven peer

9

Mirrabooka Investments (MIR)

AFIC group

Small/mid-cap long-term

Low-cost, internally managed, larger

10

Unlisted small-cap funds (e.g. boutique small-cap unit trusts and active ETFs)

Various

Small-cap

Daily liquidity at NAV; no discount risk

Competitor Detail

MetricRyder Capital (RYD)

Net assets / gross assets (AUD Mn)

148.5 (Jun-26); 185.7 gross (Sep-26)

FY26 pre-tax NTA return (%)

33.53

3-year pre-tax NTA return (% p.a., Sep-26)

34.22

Management fee (% p.a.)

1.25 + GST

Performance fee

20% over RBA + 4.25%

Price / pre-tax NTA (Sep-26)

0.96x

Recent Developments

Not identified in the sources reviewed: * litigation, regulatory actions, layoffs or restructurings.

Company Snapshot

2015

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Outperformance: a FY26 pre-tax NTA return of 33.53% against Small Ords +8.11%, the third straight year above 25% (FY24 +24.96% undiluted; FY25 +27.16%; FY26 +33.40%).
  • Process quality: a since-inception win/loss ratio of 79.15% and a profit-to-loss multiple of 4.80x (A$124.0m net realised profits).
  • Risk-adjusted returns: a 3-year Sharpe of 1.63 versus 0.41 (Small Ords) and a 3-year Sortino of 3.01 versus 0.61.
  • Dividend capacity: a franking account of A$10.95m (adjusted A$19.28m) and a distributable reserve of 72 cps, supporting the 12 cps policy for more than five years.
  • Alignment: directors and related parties own 18.31m shares (22.7%), including 4.19m held directly by the manager.
  • Balance sheet: ungeared, with A$15.02m bank cash at June 2026 and A$16.44m portfolio cash at September 2026.

Weaknesses

  • Governance: only 1 of 4 directors is independent, the executive chair is also the manager's CIO, and there is no separate nomination or remuneration committee.
  • Fee load: FY26 total expenses of A$5.06m equal 3.68% of average net assets, and the performance fee is benchmarked to cash plus 4.25%, not an equity index.
  • Concentration: BCI is 20.14% of the portfolio and the top seven positions about 59% (September 2026).
  • Scale: about A$186m gross assets limits liquidity and institutional ownership.
  • Volatility: drawdowns of −21.47% (FY22), −15.77% (May 2023) and −9.58% (March 2026), and a −8.88% NTA return in 2H FY26.
  • Statutory earnings optics: EPS of 0.53 cents and a P/E of about 400x per aggregators, because of FVOCI accounting, which confuses screens.

Opportunities

  • BCI Minerals: Mardie's first salt on ship is guided for the March quarter of 2027. Construction was 85% complete, with about A$258m left to spend and about A$423m liquidity. A sulphate of potash pilot plant was awarded in August 2026.
  • OFX takeover: A$1.00 cash versus A$0.615 at 30 September 2026 (+63% upside on a 5.68% weight if completed).
  • Vitrafy: access to about 174 US blood collection sites (about 18% of the US addressable market), FDA registration expected by the end of calendar 2026, and A$41.2m cash.
  • Cuscal: guidance for mid-20s% growth in volumes and NPAT in FY27, the Paymark acquisition, and ASX 300 inclusion.
  • Market dislocation: higher-for-longer rates and AI-driven sell-offs create mispricing for a cash-rebuilding value investor (8.85% cash, still below target).
  • Discount narrowing / premium: shares at 0.96x pre-tax NTA but about 1.06x post-tax NTA (September 2026). A premium would allow accretive capital raising.

Threats

  • Macro: RBA tightening (4.60%), CPI at 4.0% and oil above US$100 weigh on small-cap valuations.
  • Deal risk: OFX debt financing is unresolved, exclusivity runs to 30 October 2026, and OFX has downgraded FY27 expectations.
  • Single-asset execution risk at BCI: first salt shipment has already slipped after two late-season cyclones.
  • Level 3 valuation risk: Updater carries A$6.76m on a DCF (17.5% discount rate) and is unhedged in US dollars.
  • Key-person risk: the strategy depends on Constable and a two-person support team.
  • Sector headwinds for LICs: structural discounts and competition from active ETFs.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr to Jun 2025Monthly NTA returns of +4.80% (Apr), +2.35% (May), +3.01% (Jun) HeatmapStrong close to FY25
8 Jul 2025FY25 final dividend of 5.5 cps declared (+10%); DRP suspended FY26 Appendix 4ELifts FY25 dividends to 10.0 cps; avoids dilutive scrip at a discount
Jul 2025Participates in the Tetratherix IPO FY26 IM ReportNew healthcare exposure
Aug 2025+13.09% NTA month, one of the strongest in Ryder's history HeatmapDrives the strong 1H FY26
15 Aug 2025FY25 results: total comprehensive income A$21.8m (+20%), NTA return 27.50% FY25 ReleaseSecond consecutive year above 25%
Sep 202510th anniversary of listing FY26 Chairman's LetterTrack-record milestone
15 Oct 2025Quarterly dividend policy announced; share price rose about 10.6% that day to A$1.78 InvestSMARTRe-rates income appeal; narrows discount
Oct 2025FY25 AGM held (date n/d) QuartrShareholder engagement
6 Jan 2026First quarterly dividend of 3.0 cps declared (paid 27 Jan 2026) ASX releasePolicy implemented
19 Feb 20261H FY26: record total comprehensive income A$42.53m (+227%); pre-tax NTA A$2.2476 1H FY26 ReleasePeak NTA for FY26
Feb to Mar 2026OFX (portfolio holding) announces a strategic review (5 Feb 2026) OFX ASX releaseSets up the later takeover proposal
Mar 2026"SaaSpocalypse" tech sell-off: −9.58% NTA month Heatmap; FY26 IM ReportLargest monthly drawdown since May 2023; Ryder buys software stocks
Mar 2026Lumos receives FDA CLIA Waiver for FebriDX; Updater warrants restructured FY26 IM ReportKey portfolio catalysts
1 Apr 2026March-quarter dividend of 3.0 cps declared (paid 23 Apr) FY26 Directors' ReportPolicy continuity
May 2026−3.36% NTA month; Jane Corish appointed Company Secretary Heatmap; Directors' ReportGovernance
Jun 2026FDC Consolidated IPO participation (A$3.56m); Macmahon fully exited; Vitrafy A$30m placement FY26 Note 3; Sep-26 LetterCapital recycling
1 Jul 2026June-quarter dividend of 3.0 cps declared (paid 21 Jul) ASX releaseCompletes FY26 policy year
8 Jul 2026June 2026 NTA: pre-tax A$1.9803, post-tax A$1.8390; FY27 dividend intention confirmed Jun-26 NTAYear-end marker
9 Jul 2026FDC Consolidated lists on the ASX FY26 Note 3Level 2 to Level 1 transfer
23 Jul 2026OFX enters a Transaction Process Deed with Equals at A$1.00 cash (about +80% versus Ryder's June mark) OFX release; FY26 IM ReportPotential A$4m+ uplift on Ryder's position
14 Aug 2026FY26 results and Annual Report: total comprehensive income A$31.80m; TSR 41.92%; 12 cps FY27 base confirmed; Pitcher Partners first audit FY26 Annual ReportRecord year
Aug 2026+9.42% NTA month; gains in Count, BCI, Chrysos and Vitrafy; FDC exited; SiteMinder downgrade Aug-26 NTAStrong reporting season
9 Sep 2026August NTA: pre-tax A$2.2126; share price A$2.11; gross assets A$182.75m Aug-26 NTANTA near record
Sep 2026Lumos options (13.7m at 7 cents) exercised; Nufarm, Coast and Polymetals exited; RBA lifts cash to 4.60% (29 Sep) Sep-26 LetterHigher hurdle; cash rebuilt to 8.85%
Late Sep 2026Q1 FY27 dividend of 3.0 cps declared (payable 22 Oct 2026) Sep-26 LetterPolicy continuity
Sep 2026OFX downgrades FY27 expectations; Equals exclusivity extended to 30 Oct 2026 pending debt financing Sep-26 Letter; OFX releasesDeal-completion risk on a 5.7% holding
Early Oct 2026September NTA: pre-tax A$2.2395 (+1.21%); market cap A$172.38m; BCI 20.14% weight Sep-26 NTAHighest month-end pre-tax NTA in the sources reviewed below the Dec-25 peak of A$2.2476
8 Oct 2026September-quarter shareholder letter: +14.88% quarter, rolling 1-year +19.93% Sep-26 LetterStrong FY27 start
21 Oct 2026 (upcoming)AGM FY26 Annual ReportRoutine resolutions; FY27 year-to-date update

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment (%): Share of total revenue held from 100% in FY2024 to 100% in FY2026.
Ryder Capital Limited — Revenue by Segment (%)
Series (%)FY2024FY2025FY2026
Share of total revenue100100100

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.